Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies that are capable of specifically binding tissue factor pathway inhibitor

Antibodies that are capable of specifically binding tissue factor pathway inhibitor

US Patent 9228022 · Granted Jan 5, 2016

Estimated economic value: $56,247,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (12022
Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (12022
Procoagulant antibodies2022
Coagulation factor-targeting to TREM-like transcript 1 (TLT-1) on activated plat2021
Antibodies capable of specifically binding two epitopes on tissue factor pathway2020
Antibodies capable of specifically binding two epitopes on tissue factor pathway2020
Antibodies capable of specifically binding two epitopes on tissue factor pathway2020
Antibodies against human NKG2D and uses thereof2020
Targeting tissue factor to activated platelets2018
Targeting tissue factor to activated platelets2018
Targeting tissue factor to activated platelets2018
Factor VIII polypeptide titers in cell cultures2018